IL2 and acute myeloid leukemia: In the absence of K562 target cells, NK cells of healthy individuals, of untreated AML patients, of patients after chemotherapy and of HDC plus IL-2-treated patients displayed only low spontaneous capabilities to produce IFN-γ or to display CD107a (Figure 6A, left panels).